Olink

Olink®
Part of Thermo Fisher Scientific

Longitudinal plasma proteomics in CAR T–cell therapy patients implicates neutrophils and NETosis in the genesis of CRS

Blood Advances, 2024

Flora C., Olesnavich M., Zuo Y., Sandford E., Madhukar R., Rozwadowski M., Sugur K., Ly A., Canbaz A., Shedeck A., Li G., Geer M., Yanik G., Ghosh M., Frame D., Bonifant C., Jain T., Knight J., Choi S., Tewari M.

Disease areaApplication areaSample typeProducts
Oncology
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

No abstract (Letter article)

Read publication ↗